Trius Therapeutics Inc Asset Turnover Ratio (TSRX), as of second quarter 2013, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Trius Therapeutics Inc  (TSRX)
 

Trius Therapeutics Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Trius Therapeutics Inc's asset turnover ratio, the ratio that measures the ability of Trius Therapeutics Inc's assets to generate revenue, sequentially decreased to 0.18 in the second quarter (Jun 30 2013), which does not come as a surprise, as the Trius Therapeutics Inc continue to experience difficult business climate.

Within sector 12 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Second Quarter 2013 compared to the preceding quarter from 1016 to 1017.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

TSRX Asset Turnover Ratio (Jun 30 2013)
II. Quarter		 (Mar 31 2013)
I. Quarter		 (Dec 31 2012)
IV. Quarter		 (Sep 30 2012)
III. Quarter		 (Jun 30 2012)
II. Quarter
Y / Y Asset Change -21.85 % -15.7 % 10.49 % 4.22 % 55.02 %
Y / Y Revenue Change -79.26 % -82.43 % 3.1 % -80.38 % 117.7 %
Asset Turnover Ratio (TTM) 0.18 0.22 0.3 0.31 0.59
TSRX's Total Ranking # 1017 # 1016 # 1016 # 0 # 0
Seq. Asset Change -17.55 % 19.32 % -6.2 % -15.31 % -11.06 %
Seq. Revenue Change -25.25 % -66.51 % -13.68 % -4.03 % -36.7 %



Asset Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 13
Healthcare Sector # 80
Overall Market # 1017

Asset Turnover Ratio Statistics
High Average Low
0.3 0.24 0.18
(Dec 31 2012)   (Jun 30 2013)




TSRX Company Profile • Back to TSRX Efficiency Comparisons • Compare TSRX Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Jun 30 2013, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Jun 30 2013 Assets at quarter ending Jun 30 2013
Celgene Corp  0.51 $ 5,930.261  Millions$ 11,689.858  Millions
Emergent Biosolutions Inc   0.50 $ 384.599  Millions$ 771.351  Millions
Medtronic Plc  0.48 $ 16,664.000  Millions$ 34,668.750  Millions
Gilead Sciences Inc   0.47 $ 10,313.911  Millions$ 21,759.927  Millions
Cytocore Inc  0.47 $ 0.083  Millions$ 0.177  Millions
China Pediatric Pharmaceuticals, Inc.  0.47 $ 4.991  Millions$ 10.645  Millions
Nektar Therapeutics  0.46 $ 215.017  Millions$ 463.715  Millions
Emeritus Corpwa  0.46 $ 1,721.023  Millions$ 3,724.164  Millions
Dendreon Corp  0.45 $ 304.373  Millions$ 669.762  Millions
Neurometrix Inc   0.44 $ 5.513  Millions$ 12.447  Millions
Bristol myers Squibb Company  0.44 $ 15,806.000  Millions$ 36,037.750  Millions
Wright Medical Group N v   0.43 $ 417.692  Millions$ 976.506  Millions
Viropharma Inc  0.43 $ 531.644  Millions$ 1,243.944  Millions
Merck and Co Inc   0.42 $ 44,907.000  Millions$ 106,377.250  Millions
Bio techne Corp  0.42 $ 310.575  Millions$ 743.897  Millions
Alerislife Inc   0.42 $ 2,950.413  Millions$ 7,107.272  Millions
Boston Scientific Corporation  0.41 $ 7,126.000  Millions$ 17,182.750  Millions
Ligand Pharmaceuticals Incorporated  0.41 $ 41.241  Millions$ 99.925  Millions
Nutrastar International Inc.  0.40 $ 39.160  Millions$ 96.821  Millions
Cyteir Therapeutics Inc   0.40 $ 1,438.600  Millions$ 3,621.125  Millions
Lexaria Bioscience Corp   0.34 $ 1.325  Millions$ 3.899  Millions
Amgen Inc   0.33 $ 17,657.000  Millions$ 53,499.000  Millions
Pathfinder Cell Therapy, Inc.  0.32 $ 0.097  Millions$ 0.306  Millions
Beam Therapeutics Inc   0.30 $ 2,551.900  Millions$ 8,466.625  Millions
Pfizer Inc  0.30 $ 54,427.000  Millions$ 183,783.500  Millions
Dyne Therapeutics Inc   0.30 $ 1,408.000  Millions$ 4,761.750  Millions
Xstelos Holdings, Inc.  0.24 $ 27.969  Millions$ 116.418  Millions
Viskase Holdings inc   0.22 $ 40.007  Millions$ 180.799  Millions
Nuo Therapeutics, Inc.  0.18 $ 8.603  Millions$ 47.305  Millions
Trius Therapeutics Inc  0.18 $ 14.147  Millions$ 79.850  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.